Advanced search
Publication Cover
International Journal of Neuroscience Volume 132, 2022 - Issue 5
Submit an article Journal homepage
112
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Evaluating rates of reporting symptoms of Parkinson’s disease psychosis: provider versus targeted questionnaire

Jessica Gregera Dent Neurologic Institute, Amherst, NY, USA;b School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA
,
Traci Aladeena Dent Neurologic Institute, Amherst, NY, USA;b School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USACorrespondence[email protected]
,
Michelle Rainkaa Dent Neurologic Institute, Amherst, NY, USA;b School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY, USA
,
Anupama Kalea Dent Neurologic Institute, Amherst, NY, USA
&
Horacio Capotea Dent Neurologic Institute, Amherst, NY, USA
Pages 459-465 | Received 17 Jun 2020, Accepted 22 Aug 2020, Published online: 22 Sep 2020

References

  • Forsaa EB, Larsen JP, Wentzel-Larsen T, et al. A 12-year population-based study of psychosis in Parkinson disease. Arch Neurol. 2010;67(8):996–1001.
  • Bugalho P, da Silva JA, Cargaleiro I, et al. Psychiatric symptoms screening in the early stages of Parkinson's disease. J Neurol. 2012;259(1):124–131.
  • Chaudhuri KR, Prieto-Jurcynska C, Naidu Y, et al. The nondeclaration of nonmotor symptoms of Parkinson's disease to health care professionals: an international study using the nonmotor symptoms questionnaire. Mov Disord. 2010;25(6):704–709.
  • Ravina B, Marder K, Fernandez HH, et al. Diagnostic criteria for psychosis in Parkinson's disease: report of an NINDS, NIMH work group. Mov Disord. 2007;22(8):1061–1068.
  • Ffytche DH, Creese B, Politis M, et al. The psychosis spectrum in Parkinson disease. Nat Rev Neurol. 2017;13(2):81–95.
  • Goetz CG, Fan W, Leurgans S, et al. The malignant course of "benign hallucinations" in Parkinson disease. Arch Neurol. 2006;63(5):713–716.
  • Chang A, Fox SH. Psychosis in Parkinson's disease: Epidemiology, pathophysiology, and management. Drugs. 2016;76(11):1093–1118.
  • Mills R, Friedman J, Ondo W, et al. Efficacy and tolerability of NuplazidTM (pimavanserin) in PD psychosis: Analysis of an integrated phase 3 placebo-controlled dataset. Parkinsonism Relat Disord. 2016;22:e92.
  • Gallagher DA, Lees AJ, Schrag A. What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them? Mov Disord. 2010;25(15):2493–2500.
  • de Lau LML, Verbaan D, van Rooden SM, et al. Relation of clinical subtypes in Parkinson's disease with survival. Mov Disord. 2014;29(1):150–151.
  • Factor SA, Feustel PJ, Friedman JH, et al. Longitudinal outcome of Parkinson's disease patients with psychosis. Neurology. 2003;60:1756–1761.,
  • Hermanowicz N, Edwards K. Parkinson's disease psychosis: Symptoms, management, and economic burden. Am J Manag Care. 2015;21(10 Suppl):S199–S206.
  • Martinez-Martin P, Rodriguez-Blazquez C, Forjaz MJ, et al. Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease. Parkinsonism Relat Disord. 2015;21(6):629–634.
  • Marsh L, Williams JR, Rocco M, et al. Psychiatric comorbidities in patients with Parkinson disease and psychosis. Neurology. 2004;63(2):293–300.
  • Muzerengi S, Contrafatto D, Chaudhuri KR. Non-motor symptoms: identification and management. Parkinsonism Relat Disord. 2007;13:S450–S456.
  • Aarsland D, Kramberger MG. Neuropsychiatric symptoms in Parkinson's disease. J Parkinsons Dis. 2015;5(3):659–667.
  • Ondo WG, Sarfaraz S, Lee M. A novel scale to assess psychosis in patients with Parkinson's disease. J Clin Mov Disord. 2015;2:17–21.
  • Kulick CV, Montgomery KM, Nirenberg MJ. Comprehensive identification of delusions and olfactory, tactile, gustatory, and minor hallucinations in Parkinson's disease psychosis. Parkinsonism Relat Disord. 2018;54:40–45.
  • Cummings JL, Mega M, Gray K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994;44(12):2308–2314.
  • Lai CKY. The merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disorders. Clin Interv Aging. 2014;9:1051–1061.
  • Andreasen N. The scale for the assessment of positive symptoms (SAPS). Iowa City: University of Iowa; 1984.
  • Shine JM, Mills J, Qiu J, et al. Validation of the Psychosis and Hallucinations Questionnaire in non-demented patients with Parkinson's disease. Mov Disord Clin Pract. 2015;2(2):175–181.,
  • Williams DR, Warren JD, Lees AJ. Using the presence of visual hallucinations to differentiate Parkinson's disease from atypical Parkinsonism. J Neurol Neurosurg Psychiatry. 2008;79(6):652–655.
  • Fahn S, Marsden CD, Goldstein M, et al. Recent developments in Parkinson’s disease. Vol. 2, Florham Park, NJ: Macmillan Health Care Information; 1987.
  • Goetz CG, Tilley BC, Shaftman SR, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord. 2008;23(15):2129–2170.
  • Fénelon G, Alves G. Epidemiology of psychosis in Parkinson's disease. J Neurol Sci. 2010;289(1-2):12–17.
  • Greger G, Aladeen T, Rainka M, et al. Evaluating rates of reporting symptoms of Parkinson’s disease psychosis: provider vs. targeted questionnaire [abstract and poster]. Presented at: Proceedings of American Society of Health Systems Pharmacists Midyear Conference; 2019 Dec 8-12; Las Vegas, NV. Bethesda, MD: ASHP; 2019. Poster nr 8–258.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.